Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Prestige Consumer Healthcare (PBH) stock in plain English

Free brief · no signupStart here
PBHPublished Nov 16, 2026
Prestige Consumer Healthcare Inc
Healthcare · Drug Manufacturers - Specialty & Generic
Sells over-the-counter medications, feminine hygiene items, and pediatric care supplies through mass retailers, supermarkets, and pharmacies.
Assets:
Portfolio of over 50 OTC brandsIncludes established names like Dramamine, Clear Eyes, and Fleet
Distribution across retail channelsSupplies thousands of pharmacies, supermarkets, and mass retailers in North America
Outsourced manufacturing modelRelies on external contract manufacturers for the majority of product supply
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

61
OPS ScoreOperating finances
Latest quote
-2.02%$49.60
$2.35B
15.3×
$1.17B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 16, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was PBH. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Prestige Consumer Healthcare (PBH) do?

Prestige Consumer Healthcare Inc (PBH) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Sells over-the-counter medications, feminine hygiene items, and pediatric care supplies through mass retailers, supermarkets, and pharmacies. It outsources almost all manufacturing to third parties while managing marketing and retail distribution for. It is worth $2.35B on the market and sold $1.17B over the last year.

Market cap
$2.35B
P/E ratio
15.3×
Annual sales
$1.17B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Brief updated
Nov 16, 2026

Brands and businesses behind PBH

  • Clear Eyes: Sells eye drops and redness relief products to mass retail pharmacies and online platforms.
  • Summer's Eve: Sells feminine hygiene washes, cloths, and sprays through retail drugstores and supermarkets.
  • Fleet: Sells laxatives, enemas, and digestive health treatments through pharmacies and grocery chains.
  • Dramamine: Sells motion sickness relief tablets and chews directly through retail stores and pharmacies.
  • Monistat: Sells over-the-counter yeast infection treatments and test kits through retail pharmacies and mass merchants.
  • Compound W: Sells wart removal treatments, bandages, and cryotherapy kits through drugstores and mass retailers.

PBH’s flags, in plain English

Each flag is a number from Prestige Consumer Healthcare’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.

Stupid Cash

Can pay this year's bills 2.9 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Cheap on Cash Flow

Priced at 11 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Fat Margins

Profit margin of 13.3%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.

Growth Cooling

Sales growth slowed to 2.9% a year over 5 years. Sales are growing more slowly than before, which makes the current share price harder to justify.

1 more green flag open with the free trial. Try it free for 7 days.

Questions about PBH

How big is Prestige Consumer Healthcare?

Prestige Consumer Healthcare’s market cap is $2.35B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.17B: what customers paid the company over the last year, before any costs.

What is PBH’s P/E ratio?

PBH’s P/E ratio is 15.3×. Investors pay about 15.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with PBH?

The company carries over one billion dollars in long-term debt from past brand acquisitions. That is one risk on Prestige Consumer Healthcare’s card. Its first risk flag is Growth Cooling, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Prestige Consumer Healthcare’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PBH’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card